Company / Depreciation & Amortization
ABEONA THERAPEUTICS INC. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$2.5M
FY2025
5-year range
$2.3M / $4.6M
FY2021-FY2025
Trend
+11.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization returned to growth in FY2025 after 4 years of decline, reaching $3M.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of -20.1%.
Improved from $3M to $3M over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -7.8%
- 5-Year CAGR
- -20.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -20.1%, indicating a declining trend.
- In FY2025, depreciation & amortization increased 11.4% year-over-year.
- Peak depreciation & amortization was recorded in FY2020.
- Lowest depreciation & amortization in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.42 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.5M | +11.4% |
| FY2024 | $2.3M | -26.0% |
| FY2023 | $3.1M | -4.8% |
| FY2022 | $3.3M | -29.1% |
| FY2021 | $4.6M | -41.3% |
| FY2020 | $7.8M | +955.2% |
| FY2019 | $741.0K | -68.6% |
| FY2018 | $2.4M | +218.5% |
| FY2017 | $741.0K | +34.5% |
| FY2016 | $551.0K | +4909.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026